KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EBT (2016 - 2025)

Exact Sciences (EXAS) has disclosed EBT for 16 consecutive years, with -$85.1 million as the latest value for Q4 2025.

  • Quarterly EBT rose 90.29% to -$85.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$203.9 million through Dec 2025, up 80.32% year-over-year, with the annual reading at -$203.9 million for FY2025, 80.32% up from the prior year.
  • EBT for Q4 2025 was -$85.1 million at Exact Sciences, down from -$17.8 million in the prior quarter.
  • The five-year high for EBT was $1.0 million in Q3 2023, with the low at -$876.0 million in Q4 2024.
  • Average EBT over 5 years is -$145.8 million, with a median of -$104.7 million recorded in 2024.
  • The sharpest move saw EBT skyrocketed 100.69% in 2023, then tumbled 3688.49% in 2024.
  • Over 5 years, EBT stood at -$224.9 million in 2021, then skyrocketed by 42.22% to -$129.9 million in 2022, then soared by 61.23% to -$50.4 million in 2023, then tumbled by 1638.86% to -$876.0 million in 2024, then surged by 90.29% to -$85.1 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$85.1 million, -$17.8 million, and -$57000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.